Diagnostic Approach to Children with Unexplained Global Developmental Delay in Pediatric Neurology Outpatient Clinic
Neuropediatrics · 01.04.2025 · 56 (02) · 125-132
DOI: 10.1055/a-2430-0494 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neuropediatrics, erschienen am 01.04.2025. Verfasst von Airin Veronese und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Developmental Disabilities. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Global developmental delay (GDD) is a common pediatric disorder that affects up to 3% of children. Due to the heterogeneous etiology of GDD, diagnostic procedures and algorithms are complex and diverse. The aim of our study was to investigate the diagnostic yield of genetic, metabolic, and imaging studies in establishing the etiology of unexplained GDD (UGDD).
Methods
In this retrospectively observational study, we examined the medical records of all children diagnosed with UGDD at the Department of Pediatric Neurology, University Medical Centre Ljubljana, Slovenia, between January and December 2019. We evaluated the effectiveness of various genetic, metabolic, and magnetic resonance imaging (MRI) tests in identifying the underlying cause of GDD. Additionally, we assessed subgroups of patients to determine whether any of the studied tests were particularly beneficial based on their clinical symptoms.
Results
A total of 123 patients met the inclusion criteria, with a median age of 4.3 years (range, 0–16 years), of which 71 (57.7%) were males. Genetic diagnosis was established in 47.1% (58/123) of patients. Metabolic laboratory testing did not identify a metabolic disease in any of the tested participants (114/123) and MRI was critical for diagnosis in only 1/81 (1.2%) patient.
Conclusion
Our findings strongly suggest that genetic testing surpasses MRI and metabolic testing in establishing the etiology of UGDD in a pediatric neurology outpatient setting. This information will help guide the diagnostic evaluation of these children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatric Neurology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.
- University of Ljubljana, Faculty of Medicine, Center for Developmental Neuroscience, Ljubljana, Slovenia.
- Clinical Institute for Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
- Department of Gynaecology and Obstetrics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Zitieren
APA
Veronese, A., Osredkar, D., Lovrečić, L., & Troha Gergeli, A. (2025). Diagnostic Approach to Children with Unexplained Global Developmental Delay in Pediatric Neurology Outpatient Clinic. Neuropediatrics, 56(02), 125-132. https://doi.org/10.1055/a-2430-0494
Vancouver
Veronese A, Osredkar D, Lovrečić L, Troha Gergeli A. Diagnostic Approach to Children with Unexplained Global Developmental Delay in Pediatric Neurology Outpatient Clinic. Neuropediatrics. 2025;56(02):125-132. doi:10.1055/a-2430-0494
BibTeX
@article{Veronese2025,
author = {Veronese, Airin and Osredkar, Damjan and Lovrečić, Luca and Troha Gergeli, Anja},
title = {Diagnostic Approach to Children with Unexplained Global Developmental Delay in Pediatric Neurology Outpatient Clinic},
journal = {Neuropediatrics},
year = {2025},
volume = {56},
number = {02},
pages = {125--132},
doi = {10.1055/a-2430-0494}
}
EUVIMED